Litcius/Paper detail

Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial

Jennifer S. Hanberg, Xiaoqing Fu, Xiaosong Wang, Naomi J. Patel, Yumeko Kawano, Abigail E. Schiff, Emily Kowalski, Claire Cook, Kathleen M.M. Vanni, Krishan Guzzo, Grace Qian, Katarina J Bade, Alene Saavedra, Rathnam Venkat, Shruthi Srivatsan, Yuqing Zhang, Jeffrey A. Sparks, Zachary S. Wallace

2023The Lancet Rheumatology16 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAntirheumatic drugsRheumatic diseaseCoronavirus disease 2019 (COVID-19)DiseaseAutoimmune diseaseImmunologyAntirheumatic AgentsClinical trialRheumatoid arthritisInternal medicineInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchRheumatoid Arthritis Research and TherapiesCOVID-19 Clinical Research Studies
Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial | Litcius